Logo

TOP

KGOG Clinical Trials Search

Recruitment Status

Clinical Trial Phase

IIT/SIT

Search Reset

  • Finished

    gynecological cancer
    (KGOG3005)

    Retrospective-A clinicopathologic analysis of pseudomyxoma peritonei

    • PIJae-Kwan Lee
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 52 / 0 (0.0%)
  • Finished

    gynecological cancer
    (KGOG3004)

    Comparative study of treatment modalities for Malignant Ovarian Germ cell tumor in Korea; Multicenter Retrospective study

    • PIKi Heon Lee
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 326 / 0 (0.0%)
  • Finished

    gynecological cancer
    (KGOG3003)

    Retrospective-Clear cell carcinoma (CCC) of the ovary

    • PISang-Young Ryu
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 205 / 150 (136.7%)
  • Finished

    gynecological cancer
    (KGOG3002)

    • PIKi Heon Lee
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 0 / 0 (0.0%)
  • Finished

    gynecological cancer
    (KGOG3001)

    An Open label, Single arm and Multi-center Phase II Clinical Trial of Gemcitabine Triplet (Paclitaxel + Carboplatin + Gemcitabine) as Consolidation Chemotherapy in Patients with Advanced Epithelial Ovarian Cancer

    • PISeung Cheol Kim
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 0 / 69 (0.0%)
  • Finished

    gynecological cancer
    (KGOG2028)

    • PIMin Kyu Kim
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 0 / 0 (0.0%)
  • Finished

    gynecological cancer
    (KGOG2026)

    RACHAEL PRO: Rate of occult atypical hyperplasia or cancer in women with non-atypical endometrial hyperplasia

    • PIKidong Kim
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 0 / 184 (0.0%)
  • Finished

    gynecological cancer
    (KGOG2018)

    GOG-275: A Phase III Randomized Trial of Pulse Actinomcyin-D versus Multi-day Methotrexate for the Management of Low Risk Gestational TrophoblasticNeoplasia

    • PIJeong-Won Lee
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 57 / 384 (14.79%)
  • Finished

    gynecological cancer
    (KGOG2017)

    Retrospective-Synchronous ovarian cancer in young patients

    • PISeok Ju Seong
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 21 / 0 (0.0%)
  • Finished

    gynecological cancer
    (KGOG2016)

    Retrospective-Stage IVB multi-center nationwide data collection

    • PIJae-Weon Kim
    • Registration Date/ Last Update Posted 2022-05-10/ 2023-03-28
    • Current Enrollment / Estimated Enrollment 0 / 100 (0.0%)

* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.